Joint drug distribution

Green Cross President Huh Eun-chul, left, poses with Isu Abxis CEO Kim Dae-sung, after signing a business alliance agreement to jointly market medicines for rare diseases at the Green Cross headquarters in Yongin, Gyeonggi Province, Tuesday. Under the accord, Green Cross will distribute Abcertin, Isu Abxis’s drug for Gaucher’s disease. The firm has distributed Fabagal, Isu Abxis’s medicine for Fabry disease, since 2014. / Courtesy of Green Cross